Tom McDonald

Tom McDonald is a seasoned global clinical R&D leader with expertise in biospecimen and investigational supply chain management. Currently serving as the Biospecimen Operations & Logistics Director at Amgen, Tom drives operational excellence and innovation in clinical trials. Previously, Tom held significant roles at Bristol Myers Squibb, where accomplishments included designing a novel logistics strategy that yielded over $2M in annual savings and implementing a hybrid logistics model that saved more than $50K per protocol. With a diverse background in clinical supply operations, Tom has contributed to organizations like Fisher Clinical Services, Merck, and Johnson & Johnson, demonstrating a strong commitment to optimizing supply chains and vendor management.